![]() |
![]() |
![]() |
![]() |
![]() |
Mexico says US court agrees to hear suit against gunmakers Mexico City, Aug 21 (AFP) Aug 21, 2021 Mexico said Friday that a court in the United States had agreed to hear its lawsuit against major gunmakers over cross-border firearms trafficking that it blames for fueling drug-related violence. A federal court in Massachusetts accepted to consider the suit against companies "responsible for the negligent trade in weapons used by criminals here," Mexican Foreign Minister Marcelo Ebrard said. "It's a first great step," he wrote on Twitter. The companies named in the suit, which was filed on August 4, include Smith & Wesson, Beretta, Colt, Glock, Century Arms, Ruger and Barrett. Together they manufacture more than two-thirds of the over half a million weapons that are illegally brought into Mexico each year, according to the Mexican authorities. The Latin American country accuses US manufacturers of developing different firearm models especially for Mexican drug traffickers. Between 70 and 90 percent of all weapons recovered from crime scenes in Mexico were smuggled in from the United States, Mexico's foreign ministry says. The lawsuit seeks compensation for the damage caused by the firms' alleged "negligent practices," as well as the implementation of adequate standards to "monitor and discipline" arms dealers. The National Shooting Sports Foundation, the US firearm industry trade association, has called the allegations "baseless" and told the Mexican government that it is responsible for crime within its own borders. Mexico has seen more than 300,000 murders since 2006 when it deployed the military in the war on drug trafficking, most of them blamed on criminal gangs. jla/dr/sw
|
|
All rights reserved. Copyright Agence France-Presse. Sections of the information displayed on this page (dispatches, photographs, logos) are protected by intellectual property rights owned by Agence France-Presse. As a consequence, you may not copy, reproduce, modify, transmit, publish, display or in any way commercially exploit any of the content of this section without the prior written consent of Agence France-Presse.
|